| Title : Hepatocellular BChE as a therapeutic target to ameliorate hypercholesterolemia through PRMT5 selective degradation to restore LDL receptor transcription - Wang_2022_Life.Sci_293_120336 |
| Author(s) : Wang D , Tan KS , Zeng W , Li S , Wang Y , Xu F , Tan W |
| Ref : Life Sciences , 293 :120336 , 2022 |
| Abstract : Wang_2022_Life.Sci_293_120336 |
| ESTHER : Wang_2022_Life.Sci_293_120336 |
| PubMedSearch : Wang_2022_Life.Sci_293_120336 |
| PubMedID: 35065166 |
Wang D, Tan KS, Zeng W, Li S, Wang Y, Xu F, Tan W (2022)
Hepatocellular BChE as a therapeutic target to ameliorate hypercholesterolemia through PRMT5 selective degradation to restore LDL receptor transcription
Life Sciences
293 :120336
Wang D, Tan KS, Zeng W, Li S, Wang Y, Xu F, Tan W (2022)
Life Sciences
293 :120336